BRPI0608758A2 - piperidinas substituìdas, preparação farmacêutica e uso das mesmas, bem como intermediário - Google Patents

piperidinas substituìdas, preparação farmacêutica e uso das mesmas, bem como intermediário

Info

Publication number
BRPI0608758A2
BRPI0608758A2 BRPI0608758-2A BRPI0608758A BRPI0608758A2 BR PI0608758 A2 BRPI0608758 A2 BR PI0608758A2 BR PI0608758 A BRPI0608758 A BR PI0608758A BR PI0608758 A2 BRPI0608758 A2 BR PI0608758A2
Authority
BR
Brazil
Prior art keywords
well
pharmaceutical preparation
substituted piperidines
substituted
piperidines
Prior art date
Application number
BRPI0608758-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Peter Herold
Robert Mah
Vincenzo Tschinke
Christiane Marti
Stefan Stutz
Frank Hollinger
Zenon D Konteatis
Jennifer L Ludington
Michael Quirmbach
Aleksandar Stojanovic
Dirk Behnke
Stjepan Jelakovic
Original Assignee
Speedel Experimenta Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Experimenta Ag filed Critical Speedel Experimenta Ag
Publication of BRPI0608758A2 publication Critical patent/BRPI0608758A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BRPI0608758-2A 2005-03-31 2006-03-30 piperidinas substituìdas, preparação farmacêutica e uso das mesmas, bem como intermediário BRPI0608758A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66655605P 2005-03-31 2005-03-31
US75085305P 2005-12-16 2005-12-16
PCT/EP2006/061197 WO2006103277A2 (en) 2005-03-31 2006-03-30 2 , 4 , 5-substituted piperidines as renin inhibitors

Publications (1)

Publication Number Publication Date
BRPI0608758A2 true BRPI0608758A2 (pt) 2009-07-07

Family

ID=36586065

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0608758-2A BRPI0608758A2 (pt) 2005-03-31 2006-03-30 piperidinas substituìdas, preparação farmacêutica e uso das mesmas, bem como intermediário
BRPI0621969-1A BRPI0621969A2 (pt) 2005-03-31 2006-03-30 piperidinas substituìdas, bem como uso das mesmas e preparação farmacêutica

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0621969-1A BRPI0621969A2 (pt) 2005-03-31 2006-03-30 piperidinas substituìdas, bem como uso das mesmas e preparação farmacêutica

Country Status (13)

Country Link
US (2) US20100029628A1 (enExample)
EP (1) EP1863803B1 (enExample)
JP (2) JP2008534558A (enExample)
AR (2) AR055756A1 (enExample)
AT (1) ATE479681T1 (enExample)
BR (2) BRPI0608758A2 (enExample)
CA (1) CA2601702A1 (enExample)
DE (1) DE602006016573D1 (enExample)
IL (2) IL186130A0 (enExample)
PL (1) PL1863803T3 (enExample)
PT (1) PT1863803E (enExample)
TW (2) TW200716622A (enExample)
WO (1) WO2006103277A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE462703T1 (de) 2004-08-25 2010-04-15 Actelion Pharmaceuticals Ltd Bicyclononen-derivate als renin-inhibitoren
TW200716622A (en) * 2005-03-31 2007-05-01 Speedel Experimenta Ag Substituted piperidines
BRPI0609890A2 (pt) 2005-05-27 2010-05-04 Actelion Pharmaceuticals Ltd composto, composição farmacêutica, e, uso de um composto
GB0514203D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
AU2007253950B2 (en) 2006-05-19 2012-05-03 Abbott Laboratories CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives
TW200815425A (en) * 2006-06-08 2008-04-01 Speedel Experimenta Ag 2,5-disubstituted piperidines
TW200821303A (en) * 2006-08-08 2008-05-16 Speedel Experimenta Ag Organic compounds
EP1958634A3 (en) * 2007-02-14 2008-09-24 Speedel Experimenta AG Substituted piperidines as inhibitors of beta-secretase, cathepsin D, plasmepsin II and/or HIV protease
TW200922596A (en) * 2007-10-25 2009-06-01 Speedel Experimenta Ag 4,4-disubstituted piperidines
TW200934499A (en) * 2007-11-02 2009-08-16 Speedel Experimenta Ag 4,4-disubstituted piperidines
BRPI0821142A2 (pt) 2007-12-19 2015-09-15 Dainippon Sumitomo Pharma Co derivados heterocíclicos bicíclicos
US8022069B2 (en) 2008-02-08 2011-09-20 Novartis Ag Substituted piperidines as renin inhibitors
MX2010008716A (es) * 2008-02-08 2010-10-25 Novartis Ag Piperidinas sustituidas como inhibidores de renina.
CA2722734C (en) 2008-05-05 2013-11-05 Merck Frosst Canada Ltd. 3,4-substituted piperidine derivatives as renin inhibitors
EP2163245A1 (en) 2008-09-10 2010-03-17 Novartis Ag Renin inhibitors for the treatment of psoriasis
WO2010132873A2 (en) 2009-05-15 2010-11-18 Northwestern University Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase
CA2765527A1 (en) 2009-06-24 2010-12-29 Satoshi Suetsugu N-substituted-cyclic amino derivative
HK1246743A1 (zh) * 2015-01-09 2018-09-14 J.W. Speaker Corporation 用於车辆的跟踪和照明系统及方法
DE102015013191A1 (de) * 2015-10-10 2017-04-13 Daimler Ag Verfahren zum Betrieb einer Leuchteinheit und Leuchteinheit

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100384979B1 (ko) * 1995-09-07 2003-10-17 에프. 호프만-라 로슈 아게 심부전증및신부전증치료용의신규한4-(옥시알콕시페닐)-3-옥시-피페리딘
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
US6197959B1 (en) * 1999-04-27 2001-03-06 Hoffmann-La Roche Inc. Piperidine derivatives
US20040204455A1 (en) * 2003-04-10 2004-10-14 Cody Wayne Livingston Piperidine derivative rennin inhibitors
TW200716622A (en) * 2005-03-31 2007-05-01 Speedel Experimenta Ag Substituted piperidines

Also Published As

Publication number Publication date
CA2601702A1 (en) 2006-10-05
TW200833687A (en) 2008-08-16
ATE479681T1 (de) 2010-09-15
PT1863803E (pt) 2010-11-18
BRPI0621969A2 (pt) 2011-07-19
EP1863803A2 (en) 2007-12-12
AR065188A2 (es) 2009-05-20
AR055756A1 (es) 2007-09-05
DE602006016573D1 (de) 2010-10-14
US7687495B2 (en) 2010-03-30
IL186130A0 (en) 2008-01-20
WO2006103277A3 (en) 2006-12-28
IL189429A0 (en) 2008-06-05
EP1863803B1 (en) 2010-09-01
US20100029628A1 (en) 2010-02-04
JP2008201787A (ja) 2008-09-04
TW200716622A (en) 2007-05-01
JP2008534558A (ja) 2008-08-28
WO2006103277A2 (en) 2006-10-05
US20080171748A1 (en) 2008-07-17
PL1863803T3 (pl) 2011-02-28

Similar Documents

Publication Publication Date Title
BRPI0608758A2 (pt) piperidinas substituìdas, preparação farmacêutica e uso das mesmas, bem como intermediário
BRPI0815547B8 (pt) composição farmacêutica compreendendo depsipeptídeos cíclicos, e seus usos
CL2010001348A1 (es) Compuestos derivados de 1-oxo-2,3-dihidro-1h-isoindolin-5-il)-isoxazol-3-carboxamida, potenciadores de los mglur2; composicion farmaceutica; y su uso para aliviar los sintomas o disminuir la aparicion de los sintomas de ezquizofrenia o ansiedad.
BRPI0611863A2 (pt) composto, bem como composiÇço e kit compreendendo o mesmo, composto intermediÁrio na preparaÇço do mesmo, mÉtodo para tratamento e uso do mesmo
BR122013025375B8 (pt) compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas
EA201170884A1 (ru) Производные пиперидина, пригодные в качестве антагонистов орексина
BRPI0518758A2 (pt) compostos de acetamida como fungicidas
BRPI0717035B8 (pt) moduladores de benzotriazol cinase
BRPI0818672B8 (pt) composições, composições farmacêuticas e usos de 2'flúor-2'-desoxitetra-hidrouridinas
BR112014007193A2 (pt) derivados de pirazoloquinolinona, preparação dos mesmos e uso terapêutico dos mesmos
BRPI0506843A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
BRPI0819328A8 (pt) Compostos inibidores de replicação de vírus da imunodeficiência humana, composição farmacêutica e uso dos ditos compostos
BRPI0518509A2 (pt) pirrolopirazàis, inibidores de cinase potentes
BRPI0408347B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
BRPI0518752A2 (pt) 1-alquinil-2-arilàxi-alquil-amidas e uso do mesmo como fungicidas
BRPI0517999A (pt) derivados de tetraidropirano como antidiabéticos
CU20100111A7 (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso para el tratamiento y prevención de enfermedades pulmonares y cardiovasculares
BR112012006531A2 (pt) derivados de imidazopirimidina ou imidazopiridina como inibidores da fosfodiesterase 10a.
BRPI0510412A (pt) compostos orgánicos
NI200900211A (es) Derivados de 7 - alquinil - 1, 8 - naftiridonas, su preparación y su aplicación en terapéutica.
BRPI0606964A2 (pt) pirrolidinas e piperidinas derivadas do acetileno para uso como antagonistas de mglur5
BRPI0612580A8 (pt) glicinamidas substituídas, processo para a sua preparação e uso da mesma como medicamentos
UY29325A1 (es) Nuevos derivados de 2 - amino-piridina
BRPI0508969A (pt) compostos orgánicos
BRPI0701664A2 (pt) 4-quinolinonas e quinolinas, processo de preparaÇço, formulaÇÕes farmacÊuticas e uso das mesmas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUI DADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2211 DE 21/05/2013.